Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,522 | 3,162 | 7,438 | 6,241 | 10,799 |
| TOTAL | $7,864 | $3,534 | $7,979 | $6,945 | $11,624 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $7,864 | $3,534 | $7,979 | $6,945 | $11,624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 461 | 808 | 866 | 497 | 515 |
| Accrued Expenses | 1,180 | 1,165 | 758 | 426 | 1,002 |
| TOTAL | $1,640 | $1,973 | $1,624 | $923 | $1,517 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,640 | $1,973 | $1,624 | $923 | $1,517 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,022 | 543 | 44 | 5 | 3 |
| Common Shares | 0 | 0 | 0 | 0 | 1 |
| Retained earnings | -73,234 | -65,675 | -53,388 | -45,593 | -35,982 |
| TOTAL | $6,223 | $1,561 | $6,355 | $6,022 | $10,107 |
| Total Liabilities And Equity | $7,864 | $3,534 | $7,979 | $6,945 | $11,624 |